Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Constellation Pharmaceuticals

Biotech & Life Sciences · Cambridge, United States · Founded 2008 · IPO 2018 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1.70B
Market cap · 2026
Revenue
$7.91B
Latest reported FY

Investors

15 investors on Constellation Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 4 investors entered at this stage
The Column Group
Venrock
Third Rock Ventures
Altitude Life Science Ventures
Series B+ 11 investors entered at this stage
OrbiMed
Fidelity Investments
Cormorant Asset Management
Genentech
SR One
Avoro Capital Advisors
Casdin Capital
Deerfield
Hillhouse Capital
Solon Mack Capital
Sirona Capital

Patent intelligence

$116M patent portfolio · 68 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value
$116M
6.8% of market cap · 1.6× the top peer TransThera Biosciences ($73M)
68 active patent families
Where Constellation Pharmaceuticals innovates Pharmaceutical medicineDiseaseMolecular biologyEnzymePharmacology
Tracks the peer median across all five Patsnap quality dimensions.

Quality vs same-sector peers

Constellation Pharmaceuticals on the five Patsnap quality dimensions

Constellation Pharmaceuticals in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Constellation Pharmaceuticals concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Constellation Pharmaceuticals and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Constellation Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo